The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease
Authors
Keywords
Erythropoietin, Alzheimer’s disease, Transferrin receptor, Blood–brain barrier, Molecular Trojan horse
Journal
NEUROMOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-17
DOI
10.1007/s12017-019-08524-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls
- (2018) Einar M. Sigurdsson JOURNAL OF ALZHEIMERS DISEASE
- Brain Shuttle Antibody for Alzheimer’s Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode
- (2018) Felix Weber et al. Cell Reports
- Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor
- (2018) William M. Pardridge et al. MOLECULAR PHARMACEUTICS
- A Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease
- (2018) Rudy Chang et al. MOLECULAR PHARMACEUTICS
- CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity
- (2018) Etrat Hooshmandi et al. NEUROSCIENCE
- Therapeutics of Neurotransmitters in Alzheimer’s Disease
- (2017) Ramesh Kandimalla et al. JOURNAL OF ALZHEIMERS DISEASE
- Epileptic activity in Alzheimer's disease: causes and clinical relevance
- (2017) Keith A Vossel et al. LANCET NEUROLOGY
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Fibril structure of amyloid-β(1–42) by cryo–electron microscopy
- (2017) Lothar Gremer et al. SCIENCE
- Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
- (2017) Greta Hultqvist et al. Theranostics
- Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
- (2017) Norelle C. Wildburger et al. Scientific Reports
- Pericytes: new EPO-producing cells in the brain
- (2016) Peng Ji BLOOD
- Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin
- (2016) Doaa M. Samy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CSF, blood-brain barrier, and brain drug delivery
- (2016) William M. Pardridge Expert Opinion on Drug Delivery
- An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease
- (2016) Yamila Rodríguez Cruz et al. JOURNAL OF ALZHEIMERS DISEASE
- Complement and microglia mediate early synapse loss in Alzheimer mouse models
- (2016) S. Hong et al. SCIENCE
- Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease
- (2016) S-S Jiao et al. Translational Psychiatry
- Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
- (2016) Yan Chen Shang et al. Aging-US
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease
- (2015) Zhen Fan et al. BRAIN
- Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid β42 in mice
- (2015) Yi-pei Li et al. BRAIN RESEARCH
- Amyloid- Impairs Synaptic Inhibition via GABAA Receptor Endocytosis
- (2015) D. Ulrich JOURNAL OF NEUROSCIENCE
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
- (2015) Sylvia Lombardo et al. NEUROPHARMACOLOGY
- Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease
- (2015) Parisa Esmaeili Tazangi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Is there still any hope for amyloid-based immunotherapy for Alzheimerʼs disease?
- (2014) Francesco Panza et al. CURRENT OPINION IN PSYCHIATRY
- Blood–brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody
- (2014) William M Pardridge Expert Opinion on Drug Delivery
- Current approaches to enhance CNS delivery of drugs across the brain barriers
- (2014) Cui-Tao Lu et al. International Journal of Nanomedicine
- Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
- (2014) Nga Bien-Ly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
- (2014) Zhentao Zhang et al. NATURE MEDICINE
- Contribution of Alzheimer disease to mortality in the United States
- (2014) B. D. James et al. NEUROLOGY
- Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
- (2014) Jens Niewoehner et al. NEURON
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Physiology and Pharmacology of Erythropoietin
- (2014) Wolfgang Jelkmann TRANSFUSION MEDICINE AND HEMOTHERAPY
- Regulation of erythropoiesis by hypoxia-inducible factors
- (2013) Volker H. Haase BLOOD REVIEWS
- Can Infections Cause Alzheimer's Disease?
- (2013) F. Mawanda et al. EPIDEMIOLOGIC REVIEWS
- Protective action of erythropoietin on neuronal damage induced by activated microglia
- (2013) Shirley D. Wenker et al. FEBS Journal
- Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimer’s disease
- (2013) Tangui Maurice et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
- (2013) J. A. Couch et al. Science Translational Medicine
- Increased in Vivo Amyloid- 42 Production, Exchange, and Loss in Presenilin Mutation Carriers
- (2013) R. Potter et al. Science Translational Medicine
- Epidemiology of Dementias and Alzheimer’s Disease
- (2012) Ana Luisa Sosa-Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Ultrasound-Induced Blood-Brain Barrier Opening
- (2012) Elisa E. Konofagou et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- Drug Transport across the Blood–Brain Barrier
- (2012) William M Pardridge JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
- (2012) Timothy Revett et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
- (2012) Gunter P. Eckert et al. MOLECULAR NEUROBIOLOGY
- From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease
- (2012) Kristina Leuner et al. MOLECULAR NEUROBIOLOGY
- Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer’s Disease
- (2012) Margarita C. Dinamarca et al. Frontiers in Physiology
- Intranasal delivery of biologics to the central nervous system
- (2011) Jeffrey J. Lochhead et al. ADVANCED DRUG DELIVERY REVIEWS
- Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse
- (2011) Qing-Hui Zhou et al. BRAIN RESEARCH
- Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia
- (2011) Yan Chen Shang et al. CURRENT NEUROVASCULAR RESEARCH
- Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer’s disease models
- (2011) Soon-Tae Lee et al. JOURNAL OF NEUROCHEMISTRY
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- The maternal and fetal impacts of obesity and gestational diabetes on pregnancy outcome
- (2010) Michael Conall Dennedy et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!
- (2010) Paul A Lapchak EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Drug Targeting of Erythropoietin Across the Primate Blood-Brain Barrier with an IgG Molecular Trojan Horse
- (2010) R. J. Boado et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Re-Engineering Erythropoietin as an IgG Fusion Protein That Penetrates the Blood−Brain Barrier in the Mouse
- (2010) Qing-Hui Zhou et al. MOLECULAR PHARMACEUTICS
- Update on the use of memantine in Alzheimer’s disease
- (2010) Rob Marum Neuropsychiatric Disease and Treatment
- Alzheimer's disease drug development and the problem of the blood-brain barrier
- (2009) William M. Pardridge Alzheimers & Dementia
- Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study
- (2009) Florence Portet et al. ARCHIVES OF NEUROLOGY
- Translational Medicine Lessons from Flurizan's Failure in Alzheimer's Disease (AD) Trial: Implication for Future Drug Discovery and Development for AD
- (2009) Hong I. Wan et al. CTS-Clinical and Translational Science
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- An Overview of APP Processing Enzymes and Products
- (2009) Vivian W. Chow et al. NEUROMOLECULAR MEDICINE
- Erythropoietin protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway
- (2009) Rong Ma et al. NEUROPHARMACOLOGY
- The Clinical Course of Advanced Dementia
- (2009) Susan L. Mitchell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse
- (2008) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Protective effect of erythropoietin on β-amyloid-induced PC12 cell death through antioxidant mechanisms
- (2008) Gang Li et al. NEUROSCIENCE LETTERS
- Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
- (2007) Fernanda G. De Felice et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search